Hepatitis C virus inhibitors

Details for Australian Patent Application No. 2010332034 (hide)

Owner Bristol-Myers Squibb Company

Inventors Belema, Makonen; Romine, Jeffrey Lee; Nguyen, Van N.; Wang, Gan; Lopez, Omar D.; St. Laurent, Denis R.; Chen, Qi; Bender, John A.; Yang, Zhong; Hewawasam, Piyasena; Xu, Ningning; Meanwell, Nicholas A.; Easter, John A.; Su, Bao-Ning; Smith, Michael J.

Agent A J Park

Pub. Number AU-A-2010332034

PCT Pub. Number WO2011/075439

Priority 12/957,512 01.12.10 US; 61/286,942 16.12.09 US

Filing date 13 December 2010

Wipo publication date 23 June 2011

International Classifications

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/075439 Priority application(s): WO2011/075439

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010332041-Continuous pitch-corrected vocal capture device cooperative with content server

2010332017-Method for production of high concentration of arginine bicarbonate solution at high pressue